SafeBeat Rx
Innovative telehealth solutions for heart rhythm disorders using AI and remote monitoring.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A | Grant | |
| Total Funding | 000k | ||
Related Content
SafeBeat Rx is a pioneering company in the telehealth sector, specializing in heart rhythm disorders. Founded by Dr. Rachita Navara, a bioengineer and cardiologist, the company leverages cutting-edge technology to bring heart health monitoring and treatment to patients wherever they are. SafeBeat Rx serves patients with heart rhythm disorders and collaborates with healthcare providers to enhance cardiac care through remote monitoring and artificial intelligence. The company operates in the healthcare technology market, focusing on telehealth and AI-driven solutions. Its business model revolves around providing subscription-based remote monitoring services and AI-powered diagnostic tools to healthcare providers and patients. Revenue is generated through service subscriptions, software licensing, and partnerships with healthcare institutions. SafeBeat Rx's multidisciplinary team includes heart rhythm physicians, data scientists, software engineers, clinical trial specialists, and regulatory experts, all dedicated to transforming cardiac care through engineering and innovation.
Keywords: telehealth, heart rhythm disorders, AI, remote monitoring, cardiac care, healthcare technology, subscription services, software licensing, diagnostic tools, innovation.